There is no product in the shopping cart, buy it!
Jump to Section
At Creative Biolabs, we specialize in making sense of protein glycosylation. As a leader in this field, we know that glycosylation is a major player in determining their function, stability, and how they interact with other molecules. We are here to help you understand why mapping glycosylation sites matters. We hold the firm belief that our services can help your research or project. There is a suite of services we provide, including but not limited to:
Glycosylation adds sugar chains to proteins, but where these chains attach (the "sites") is crucial. One protein can have multiple sites, each with different sugar structures. This variety means the same protein can act differently based on its glycosylation sites. For example, a sugar at one site might help a protein fold correctly, while a sugar at another site could let it bind to a virus or immune cell. In diseases, changes at specific sites can signal trouble, making them potential targets for new drugs or biomarkers. Our glycosylation site mapping services zero in on these sites, giving you detailed info about where sugars attach and what they do.
Fig.1 Specific glycosylation confirms the N-glycosylation at N20 site on gamma variant spike.1,3
Proteins get sugars in two main ways, each with its own rules and challenges:
N-linked glycosylation requires for a specific amino acid sequence motif, known as the N-linked glycosylation sequon. These sugars attach to a specific amino acid called asparagine (Asn), but only if it's part of a certain sequence: Asn-X-Ser/Thr (where X is any amino acid except proline). Not every Asn in this sequence gets a sugar, though—factors like protein shape and cell environment matter. We use an enzyme called PNGase F to remove these sugars, leaving a tiny mass change that our mass spectrometers can detect. This helps us confirm which Asn sites are actually "occupied" by sugars.
Here, sugars attach to serine (Ser) or threonine (Thr) amino acids. Unlike N-linked, there's no strict sequence rule, so predicting sites is harder. O-sugars can be simple or complex, and they're involved in key processes like cell signaling. We use a mix of chemical tricks, special enzymes (like OpeRATOR), and advanced mass spec to find these sites, even when they're hard to detect.
Our method is built on sensitivity and accuracy, using tools that handle even tricky samples:
Initially we extract the proteins you need from cells, tissues or fluids. During the sample preparation process we work to eliminate noise elements to concentrate on the important glycoproteins.
Our method requires enzymes such as trypsin to break down proteins into smaller peptide fragments. Some resulting peptides will contain attached sugars which makes them glycopeptides and these represent our primary targets.
Glycopeptides are often rare, so we use techniques to pull them out:
Our mass spectrometers (MS) are like molecular detectives. They measure the mass of glycopeptides and break them apart (using methods like CID or ETD) to see both the peptide sequence and the sugar structure. For N-linked sites, we look for the mass change from Asn to Asp. For O-linked, we rely on detailed fragmentation patterns to pinpoint where the sugar is attached.
We use specialized software to match the MS data to known proteins, identify potential sites, and confirm which ones are really glycosylated. This step turns raw data into clear, usable insights.
Fig.2 O-GlcNAc Site Mapping Using HCD and UVPD.2,3
Our services stand out for a few key reasons:
If you're studying virus glycoproteins, our glycosylation analysis services for virus glycoprotein are a great fit. Viral sugars are key to how they infect cells and hide from the immune system. Our analysis can help you understand these sites, which is critical for developing vaccines or antiviral drugs.
Our services make a difference in three key areas:
For biotech companies, we help ensure that therapeutic proteins—like antibodies—have the right glycosylation. This means making sure their sugar patterns are correct for safety and effectiveness. Accurate glycosylation data is essential for meeting regulatory standards and developing reliable treatments.
When studying diseases, we look for abnormal glycosylation in proteins linked to illness. By finding these changes, we can identify new biomarkers—these are like biological clues that signal a disease is present. Such clues can lead to earlier diagnosis or the development of targeted therapies that address the root cause.
In basic research, we aim to understand how sugars attached at specific sites affect how proteins work. This helps us decode fundamental cell processes, such as how the immune system responds to threats or how cells grow and communicate. These insights lay the groundwork for broader discoveries in biology.
We know this field isn't easy. Sugars come in many forms, some sites are only partly occupied, and samples can be messy. Here's how we deal with that:
Whether you're a researcher exploring basic biology or a company developing the next big therapy, knowing where and how sugars attach to proteins is key. Our glycosylation site mapping services and glycosylation analysis services for virus glycoprotein are designed to give you clear, actionable data. At Creative Biolabs, we're here to make glycosylation analysis straightforward and effective. Contact us today to talk about how we can help your project—no jargon, just practical solutions. Let's turn complex glycans into clear insights, together.
References